Avastin (bevacizumab) with carboplatin plus paclitaxel improved overall survival (OS) and progression-free survival (PFS) compared with carboplatin and paclitaxel alone in patients with metastatic mucosal melanoma, according to findings from a phase 2 study published in the Journal of Clinical Oncology.
Publications
Evaluation of treatment, prognostic factors, and survival in 198 vulvar melanoma patients: Implications for clinical practice
Researchers conducted this retrospective multicentre cohort study with the aim to determine clinicopathological characteristics, treatment patterns, clinical outcomes and prognostic factors in patients with vulvar melanoma (VM).
Survey estimates one fifth of melanomas undiagnosed during Covid-19 pandemic
A recent survey of over 700 dermatologists around the world has revealed the shocking impact of the Coronavirus pandemic on the detection of melanoma skin cancer.
Serum folate and vitamin B12 levels in cutaneous melanoma
Researchers evaluated circulating vitamin B12 and folate levels in patients suffering from melanoma and compared them with other malignant tumors as well as healthy people.